![Global Cardiac Resynchronization Therapy (CRT) Market by Type (Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]), By Application (Hospitals, Home Health Care, Ambulatory Services, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report](https://industrygrowthinsights.com/wp-content/uploads/2020/02/Report-Cover.jpg)
Market Overview:
The global cardiac resynchronization therapy (CRT) market is expected to reach USD 5.5 billion by 2030, according to a new study by Grand View Research, Inc. The increasing prevalence of heart failure and the subsequent rise in demand for CRT devices are major factors anticipated to drive the growth of the market over the forecast period. Cardiac resynchronization therapy pacemakers (CRT-P) held a dominant share in 2017 and are expected to maintain their dominance throughout the forecast period. This can be attributed to their high adoption rates due to their ability to improve heart function and symptoms associated with heart failure. Cardiac resynchronization therapy defibrillators (CRT-D) are also witnessing high adoption rates due primarily to increased awareness about these devices among patients suffering from heart failure. Hospitals emerged as the leading application segment in 2017 and is projected witness significant growth over the next decade owingto rising number of CRT procedures being performed in this setting across developed countries such as U.S., Canada, Germany, France, Italy, Spain, Japan etc. Home health care is another key application segment for CRTs owingto growing preference for home-based treatments among patients suffering from chronic diseases such as heart failure .
 Industry Outlook.svg)
Product Definition:
Cardiac Resynchronization Therapy (CRT) is a treatment for heart failure that helps the heart beat in a more coordinated way. CRT may be recommended for people who have severe heart failure and an enlarged left ventricle. The goal of CRT is to improve the efficiency of the left ventricle so that it can pump blood more effectively.
Cardiac Resynchronization Therapy Pacemakers [CRT-P]:
Cardiac resynchronization therapy pacemakers (CRT-P) is a category of cardiac assist devices that are used to treat bradycardia and heart block. It works by improving the conduction of the heart’s electrical signals, which enables it to provide a normal sinus rhythm.
Cardiac Resynchronization Therapy Defibrillators [CRT-D]:
Cardiac resynchronization therapy defibrillators, also known as CRT-D devices or electric shock machines, are used to treat cardiac arrest. They provide a continuous source of energy to the heart and allow it to resume pumping blood around the body.
The number of people suffering from cardiovascular diseases is increasing at an alarming rate worldwide.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. The other applications include cardiac rehabilitation centers, Cardiac Rehabilitation Units (CRUs), and telehealth services. These services are provided by hospitals and other healthcare facilities which offer CRT devices to patients who have suffered from heart rhythm disorders for a longer period of time or those who cannot be treated in-hospital due to some reasons.
Cardiac resynchronization therapy is mainly used for treating arrhythmia, long QT syndrome, and heart block & WPW which are associated with different conditions such as congenital heart diseases, stroke or TIA (Transient Ischemic Attack), atrial fibrillation/flutter, high blood pressure levels etc., However; each patient is carefully analyzed before undergoing any procedure according to their medical history so that the best treatment option can be selected based on individual needs.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to favorable government initiatives, increasing prevalence of cardiac disorders, and availability of highly skilled physicians. Moreover, an increase in the number of FDA approvals for various devices is also expected to drive growth during the forecast period. For instance, in December 2016, Medtronic received approval from the FDA for its Rechargeable CRT-D pacemaker system that is indicated for patients with paroxysmal atrial fibrillation (AF).
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to a large patient pool and improving healthcare infrastructure coupled with rising disposable income levels especially in developing countries such as China & India are expected boost demand over next eight years.
Growth Factors:
- Increasing prevalence of heart failure: The global incidence of heart failure is projected to increase from 26 million in 2010 to 40 million by 2030. This will create a large pool of patients who could potentially benefit from CRT therapy.
- Growing awareness and uptake of CRT: There is growing awareness among cardiologists and patients about the benefits of CRT therapy, which is helping to drive its uptake.
- Advances in technology and device design: The development of new-generation devices that are smaller, more efficient and easier to implant is helping to expand the use of CRT therapy into new patient populations.
- Rising healthcare expenditure: Globally, healthcare spending is increasing at a rapid rate, providing greater funding for medical treatments such as CRT therapy.
- Growing number of clinical studies supporting the use of CRT: A growing body evidence from clinical studies supports the efficacy and safety profileofCRTh Therapy, which is helping to increase its adoption among physicians
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Resynchronization Therapy (CRT) Market Research Report
By Type
Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]
By Application
Hospitals, Home Health Care, Ambulatory Services, Others
By Companies
Medtronic, Abbott, Boston Scientific, Biotronik, Livanova
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Resynchronization Therapy (CRT) Market Report Segments:
The global Cardiac Resynchronization Therapy (CRT) market is segmented on the basis of:
Types
Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Home Health Care, Ambulatory Services, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott
- Boston Scientific
- Biotronik
- Livanova
 Market Overview.svg)
Highlights of The Cardiac Resynchronization Therapy (CRT) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiac Resynchronization Therapy Pacemakers [CRT-P]
- Cardiac Resynchronization Therapy Defibrillators [CRT-D]
- By Application:
- Hospitals
- Home Health Care
- Ambulatory Services
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Resynchronization Therapy (CRT) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac resynchronization therapy (CRT) is a procedure that uses electrical stimulation to help the heart beat in a coordinated manner. CRT can improve the heart's ability to pump blood and reduce symptoms of arrhythmia, such as chest pain, shortness of breath, and fainting.
Some of the major players in the cardiac resynchronization therapy (crt) market are Medtronic, Abbott, Boston Scientific, Biotronik, Livanova.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Resynchronization Therapy (CRT) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Resynchronization Therapy (CRT) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Resynchronization Therapy (CRT) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Resynchronization Therapy (CRT) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Resynchronization Therapy (CRT) Market Size & Forecast, 2020-2028
4.5.1 Cardiac Resynchronization Therapy (CRT) Market Size and Y-o-Y Growth
4.5.2 Cardiac Resynchronization Therapy (CRT) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cardiac Resynchronization Therapy Pacemakers [CRT-P]
5.2.2 Cardiac Resynchronization Therapy Defibrillators [CRT-D]
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Home Health Care
6.2.3 Ambulatory Services
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Resynchronization Therapy (CRT) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Resynchronization Therapy (CRT) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cardiac Resynchronization Therapy Pacemakers [CRT-P]
9.6.2 Cardiac Resynchronization Therapy Defibrillators [CRT-D]
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Home Health Care
9.10.3 Ambulatory Services
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cardiac Resynchronization Therapy Pacemakers [CRT-P]
10.6.2 Cardiac Resynchronization Therapy Defibrillators [CRT-D]
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Home Health Care
10.10.3 Ambulatory Services
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cardiac Resynchronization Therapy Pacemakers [CRT-P]
11.6.2 Cardiac Resynchronization Therapy Defibrillators [CRT-D]
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Home Health Care
11.10.3 Ambulatory Services
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cardiac Resynchronization Therapy Pacemakers [CRT-P]
12.6.2 Cardiac Resynchronization Therapy Defibrillators [CRT-D]
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Home Health Care
12.10.3 Ambulatory Services
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cardiac Resynchronization Therapy Pacemakers [CRT-P]
13.6.2 Cardiac Resynchronization Therapy Defibrillators [CRT-D]
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Home Health Care
13.10.3 Ambulatory Services
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Resynchronization Therapy (CRT) Market: Competitive Dashboard
14.2 Global Cardiac Resynchronization Therapy (CRT) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Abbott
14.3.3 Boston Scientific
14.3.4 Biotronik
14.3.5 Livanova
